$ITMC @ 0.0995 Itoco feels that its resources and future direction will serve Shareholders best with this business strategy. The company's Board and Management came to this conclusion after much deliberation and study to assess the viability of various opportunities.

Itoco has identified Bio Tech as a sector that will grow rapidly for decades to come and that will provide multiple opportunities for our business approach.

Bio Tech is at the frontline of modern science. It is a leading technology that directly addresses the most serious challenges of our time such as hunger, energy, and disease.

Healthcare has benefited tremendously from Bio Tech especially in the areas of oncology, immunology, and regenerative therapies. These will be a special focus for Itoco.

https://finance.yahoo.com/news/itoco-announce...00395.html